Health Condition 1: null- patients with impaired liver function
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients undergoing elective ERCP with impaired liver function (i.e. raised serum bilirubin ,SGOT or SGPT levels) • Normal prothrombin time (PT) and international normalized ratio (INR) • ASA grade II. • Aged between 18 and 60 years. • Those who are willing to give written informed consent
Exclusion criteria
Exclusion criteria: • ASA grade III or more. • Patients with comorbid conditions such as HTN, DM or renal insufficiency. • Patients having difficulty in communication (due to language problem or deafness). • Patients with history of operative intervention in the past 72 hrs. • Patients with the known allergy to these drugs and with a history of sulphite ,egg or soyabean allergy • Pregnant patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare dexmedetomidine and propofol for sedative efficacy in patients with impaired liver functionTimepoint: To assess the recovery from sedation at 5 mins,10 mins, and 15 mins after procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare the sedative efficacy as well as complications of both the drugsTimepoint: 1 year | — |
Countries
India
Contacts
MD Anaesthesia & intensive care, PGI Chandigarh